Skip to main content
HURA logo

TuHURA Biosciences, Inc.

HURANASDAQHealthcareBiotechnology

$1.83Today:- (-)1Y −23.75%

As of Oct 15, 2026 close

Market cap
$117.05M
P/E (TTM)
-
Forward P/E
-
Dividend yield
-
52-week range
$0.41$3.43
Volume (live)
-
Avg. volume (3M)
211.63K

TuHURA Biosciences (HURA) Income Statement

In fiscal 2025 (fiscal year ended Mar 31, 2026), TuHURA Biosciences posted a net loss of $30.06M, compared with a net loss of $21.68M a year earlier.

TuHURA Biosciences Income Statement Analysis

Values in millions USD

Income StatementBalance SheetCash FlowRatios
Scroll to see more
TuHURA Biosciences, Inc. income statement - Annual data in millions USD
BreakdownFY 2025FY 2025FY 2024FY 2024FY 2023FY 2023FY 2022FY 2022FY 2021FY 2021FY 2020FY 2019FY 2018
Period endingMar 2026Dec 2025Mar 2025Dec 2024Dec 2023Jun 2023Dec 2022Jun 2022Dec 2021Jun 2021Jun 2020Jun 2019Jun 2018
Revenue & Gross Profit
Revenue0.00-0.00--0.00-0.00-0.000.000.000.00
Cost of Revenue0.00-0.00--0.06-0.06-0.060.030.010.02
Gross Profit0.00-0.00---0.06--0.06--0.06-0.03-0.01-0.02
Operating Expenses
Research & Development20.5320.5313.3413.349.402.667.939.314.8815.1711.823.633.66
Selling, General & Administrative7.587.583.873.874.145.732.015.432.387.459.734.504.72
Operating Expenses31.8027.2917.6517.6513.178.400.0014.747.1122.6221.548.138.38
Operating Income-31.80-27.29-17.65-17.65-13.17-8.45-9.93-14.80-7.11-22.68-21.57-8.14-8.40
Other Income/Expense
Interest Income0.140.140.36-0.360.090.090.060.06-0.000.000.080.06
Interest Expense0.630.634.14-4.140.020.02-0.000.630.630.120.000.00
Other Income/Expense1.74-2.27-4.03-4.87-16.220.130.210.150.730.02-16.73-0.980.35
Income
Income Before Tax-30.06-30.05-21.68-21.68-29.32-8.32-9.37-14.65-7.02-22.66-38.30-9.13-8.05
Income Tax Expense0.00-0.00--0.00-0.00-0.000.000.000.00
Net Income-30.06-30.05-21.68-22.65-29.32-8.32-25.13-14.65-7.02-22.66-38.30-9.13-8.05
Net Income - Continuous Operations-30.06-30.05-21.68-21.68-29.32-8.32-9.37-14.65-7.02-22.66-38.30-9.13-8.05
Net Income - Discontinued Operations-------------
EBITDA-29.36-29.36-17.43-17.09-29.12-8.27-9.56-14.59-6.01-21.97-38.15-9.12-8.03
EBIT--29.43--17.21-29.30--9.93--6.39----
Depreciation & Amortization0.070.070.120.120.180.060.370.060.380.060.030.010.02
Earnings Per Share
Basic EPS-1.00-1.00-1.00-1.00-2.00-11.00-722.00-324.00-1.00-903.00-2806.00-1532.00-5525.00
Diluted EPS-1.00-1.00-1.00-1.00-2.00-11.00-722.00-324.00-1.00-903.00-2806.00-1532.00-5525.00
Basic Shares Outstanding47.9347.9318.6618.6611.890.750.030.0512.180.030.010.010.00
Diluted Shares Outstanding47.9347.9318.6618.6611.890.750.030.0512.180.030.010.010.00

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About TuHURA Biosciences Financial Statements

Is TuHURA Biosciences profitable?

No. TuHURA Biosciences reported a net loss of $30.06M in fiscal 2025. In fiscal 2024 it lost $21.68M.

What is net profit margin?

Net profit margin is net income divided by revenue. It shows how much of each dollar of sales a company keeps as profit after all costs, interest and taxes. Full definition